S&P 500   3,100.32 (+0.43%)
DOW   27,755.96 (+0.23%)
QQQ   202.11 (+0.57%)
CGC   19.99 (-1.53%)
BABA   187.18 (+0.25%)
GE   11.55 (+1.76%)
F   9.11 (+0.33%)
PRI   129.78 (+0.43%)
BAC   33.26 (+0.24%)
S&P 500   3,100.32 (+0.43%)
DOW   27,755.96 (+0.23%)
QQQ   202.11 (+0.57%)
CGC   19.99 (-1.53%)
BABA   187.18 (+0.25%)
GE   11.55 (+1.76%)
F   9.11 (+0.33%)
PRI   129.78 (+0.43%)
BAC   33.26 (+0.24%)
Log in

KITOV PHARMA LT/S Stock Price, Forecast & Analysis (NASDAQ:KTOV)

$0.72
+0.01 (+1.41 %)
(As of 11/12/2019 11:04 AM ET)
Today's Range
$0.72
Now: $0.72
$0.72
50-Day Range
$0.71
MA: $0.74
$0.81
52-Week Range
$0.56
Now: $0.72
$2.92
Volume300 shs
Average Volume91,773 shs
Market Capitalization$14.06 million
P/E Ratio1.85
Dividend YieldN/A
Beta3.59
Kitov Pharma Ltd, through its subsidiaries, operates as a development stage biopharmaceutical company in Israel. It develops combination drugs for the simultaneous treatment of pain caused by osteoarthritis and hypertension. The company's lead drug candidate is KIT-302, a fixed dosage combination product based on the generic drugs celecoxib and amlodipine besylate that has completed its Phase III clinical study. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:KTOV
CUSIPN/A
Phone972-3933-3121

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1 million
Cash Flow$0.36 per share
Book Value$0.70 per share

Profitability

Miscellaneous

Employees10
Market Cap$14.06 million
Next Earnings DateN/A
OptionableNot Optionable

Receive KTOV News and Ratings via Email

Sign-up to receive the latest news and ratings for KTOV and its competitors with MarketBeat's FREE daily newsletter.


KITOV PHARMA LT/S (NASDAQ:KTOV) Frequently Asked Questions

What is KITOV PHARMA LT/S's stock symbol?

KITOV PHARMA LT/S trades on the NASDAQ under the ticker symbol "KTOV."

What is the consensus analysts' recommendation for KITOV PHARMA LT/S?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for KITOV PHARMA LT/S in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for KITOV PHARMA LT/S.

Has KITOV PHARMA LT/S been receiving favorable news coverage?

News articles about KTOV stock have been trending very negative on Tuesday, InfoTrie reports. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. KITOV PHARMA LT/S earned a daily sentiment score of -3.2 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for KITOV PHARMA LT/S.

Who are some of KITOV PHARMA LT/S's key competitors?

What other stocks do shareholders of KITOV PHARMA LT/S own?

Based on aggregate information from My MarketBeat watchlists, some companies that other KITOV PHARMA LT/S investors own include Southwestern Energy (SWN), Synergy Pharmaceuticals (SGYP), Sophiris Bio (SPHS), Verastem (VSTM), Advanced Micro Devices (AMD), BIOLINERX LTD/S (BLRX), Exelixis (EXEL), Progenics Pharmaceuticals (PGNX), Canopy Growth (CGC) and Achaogen (AKAO).

Who are KITOV PHARMA LT/S's key executives?

KITOV PHARMA LT/S's management team includes the folowing people:
  • Dr. John Paul Waymack, Founder, Chairman & Chief Medical Officer (Age 67)
  • Mr. Isaac Israel, CEO & Director (Age 41)
  • Dr. Hadas Reuveni, Founder & CTO of TyrNovo (Age 52)
  • Mr. Simcha Rock CPA, M.B.A., CPA, MBA, Strategic Advisor & Director (Age 69)
  • Dr. Gil Ben-Menachem M.B.A., MSc, MBA, Ph.D., VP of Bus. Devel. & Director (Age 52)

When did KITOV PHARMA LT/S IPO?

(KTOV) raised $13 million in an initial public offering (IPO) on Friday, November 20th 2015. The company issued 3,200,000 shares at $4.13 per share. Rodman & Renshaw (a unit of H.C. Wainwright & Co.,) and Joseph Gunnar acted as the underwriters for the IPO.

How do I buy shares of KITOV PHARMA LT/S?

Shares of KTOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is KITOV PHARMA LT/S's stock price today?

One share of KTOV stock can currently be purchased for approximately $0.72.

How big of a company is KITOV PHARMA LT/S?

KITOV PHARMA LT/S has a market capitalization of $14.06 million and generates $1 million in revenue each year. The company earns $-5,200,000.00 in net income (profit) each year or $0.39 on an earnings per share basis. KITOV PHARMA LT/S employs 10 workers across the globe.View Additional Information About KITOV PHARMA LT/S.

What is KITOV PHARMA LT/S's official website?

The official website for KITOV PHARMA LT/S is http://www.kitovpharma.com/.

How can I contact KITOV PHARMA LT/S?

KITOV PHARMA LT/S's mailing address is One Azrieli Center Round Tower 132 Menachem Begin Road, Tel Aviv L3, 6701101. The company can be reached via phone at 972-3933-3121 or via email at [email protected]


MarketBeat Community Rating for KITOV PHARMA LT/S (NASDAQ KTOV)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  171 (Vote Outperform)
Underperform Votes:  129 (Vote Underperform)
Total Votes:  300
MarketBeat's community ratings are surveys of what our community members think about KITOV PHARMA LT/S and other stocks. Vote "Outperform" if you believe KTOV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KTOV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/12/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel